Cardiol Therapeutics Inc.
CRDL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,964 | -$8,354 | -$8,288 | -$8,178 |
| Dep. & Amort. | $26 | $25 | $25 | $48 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4,000 | $2,540 | $1,147 | $3,147 |
| Change in WC | -$622 | $671 | -$152 | $990 |
| Other Non-Cash | -$364 | $567 | $114 | -$1,601 |
| Operating Cash Flow | -$6,925 | -$4,551 | -$7,154 | -$5,593 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$6 | -$12 | -$6 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$3 | -$6 | -$12 | -$6 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$14 | -$14 | -$14 | -$14 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $34 | $0 | $18,704 |
| Financing Cash Flow | -$14 | $20 | -$14 | $18,691 |
| Forex Effect | $369 | -$561 | -$108 | $1,604 |
| Net Chg. in Cash | -$6,573 | -$5,098 | -$7,287 | $14,695 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18,195 | $23,293 | $30,580 | $15,885 |
| End Cash | $11,622 | $18,195 | $23,293 | $30,580 |
| Free Cash Flow | -$6,928 | -$4,557 | -$7,166 | -$5,599 |